title: [Surgical treatment of 294 patients with invasive cervical cancer].
abstract: OBJECTIVE
  To establish the indices of surgical treatment (duration of operation--min, blood loss--ml, time to bowel and bladder function recovery--days) in treatment of invasive cervical cancer.
  
  
  METHODS
  Between 11.2002-11.2011 296 patients with invasive cervical cancer were operated on by the author. 294 were valuable in terms of indices of surgical treatment. The age of patients ranges from 27 to 84 years, median--48 years. 110 women were in stage IB1 (FIGO), 86--in IIB, and 98--in IB2 stage. The surgery in 81% (238 cases) was radical hysterectomy class III (RH) and pelvic lymph node dissection (LND) in 2.7% (8 cases) RH and PLN and paraaortic lymph node dissection (PLD); LEP in 8.2% (24 cases) and RH with transposition of the ovaries and PLD in 5.1% (15 cases).
  
  
  RESULTS
  The median duration of operations (only RH and LND) was 124 minutes, the median blood loss--480 ml. Blood transfusion was performed in 37% of cases. The median time for bladder and bowel function recovery was 22 and 3 days, respectively.
  
  
  CONCLUSIONS
  Open surgery performed by experienced teams trained in good technical skills leads to blood loss and recovery of patients comparable with miniinvasive techniques.
authors.forename: Y
authors.initials: Y
authors.lastname: Kornovski
authors.forename: E
authors.initials: E
authors.lastname: Ismail
authors.forename: M
authors.initials: M
authors.lastname: Kaneva
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001011:Aorta / Q000601:surgery; D016063:Blood Loss, Surgical; D001803:Blood Transfusion; D002584:Cervix Uteri / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology / Q000601:surgery*; D008875:Middle Aged; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness / Q000473:pathology / Q000517:prevention & control; D009367:Neoplasm Staging; D010388:Pelvis / Q000473:pathology / Q000601:surgery; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000601:surgery* / Q000628:therapy